Japan, Aug. 12 -- MEDIMMUNE LTD has got intellectual property rights for 'NOVEL IL33 TYPE, MUTANT IL33, ANTIBODIES, ASSAYS, AND METHODS OF USING THE SAME.' Other related details are as follows:

Application Number: JP,2023-173336

Category (FI): C07K14/54,C07K16/24,C12N15/13,C12N15/63@Z,C12N1/15,C12N1/19,C12N1/21,C12N5/10,C12P21/08,A61K39/395@D,A61K39/395@N,A61K45/00,A61P43/00,121,A61P29/00,A61P37/08,A61P11/06,A61P11/00,A61P37/02,C12N15/24

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Oct. 5, 2023

Publication Date: Jan. 9, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....